OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
January 18, 2024
FDA’s Center for Drug Evaluation and Research released its report on new drugs approved in 2023.
January 17, 2024
The agency is reviewing data on secondary malignancies related to T-cells for approved CAR T-cell medicines.
January 15, 2024
The European Medicines Agency safety committee says there is a potential risk of neurodevelopment disorders in children born to men treated with valproate.
January 10, 2024
Cherwell Laboratories’ cleanroom microbiology solutions will join AnalytiChem’s group of seven companies across Europe, North America, and Australia.
January 09, 2024
The potential for superpotent drug initiated the voluntary recall.
The expansion will boost solid-phase peptide synthesis total reactor volume to 32,000 L.